Target Price | CHF19.00 |
Price | CHF24.95 |
Deviation |
23.85%
register free of charge
|
Number of Estimates | 1 |
1 Analyst has issued a Kuros Biosciences price target 2025.
The average Kuros Biosciences target price is CHF19.00.
This is
23.85%
register free of charge
|
|
A rating was issued by 1 analysts: 1 Analysts recommend Kuros Biosciences to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Kuros Biosciences stock has an average upside potential 2025 of
23.85%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million CHF | 33.56 | 77.20 |
86.55% | 130.04% | |
EBITDA Margin | -18.33% | 11.92% |
55.27% | 165.05% |
1 Analyst has issued a sales forecast Kuros Biosciences 2024 . The average Kuros Biosciences sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Kuros Biosciences 2024 . The average Kuros Biosciences EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
EV/Sales | 12.03 |
Based on analysts' sales estimates for 2024, the Kuros Biosciences stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Kuros Biosciences...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.